Coronel-Brizio P, Palafox SF, Olivares NJ, Díaz DEZ, Ortega LN

Language: Spanish
References: 11
Page: 6-10
PDF size: 255.72 Kb.

ABSTRACT

The incidence of this Neoplasm may vary depending on the geographic area (urban, suburban and rural) because it is more likely to increase in incidence in rural areas then in urban areas where Health Services are closer to the population, giving better information on the Risk Factors of this Pathology. It has been demonstrated that the cervical cytology is done less on rural residents than in the cities, where Cervical Cancer (CUC) is diagnosed at an older age in an advanced stage. There are studies that show no sufficient evidence of increased mortality related to geographical distribution. Objetive. Examining the incidence among women with CUC to who attend the Cancer Center (CECan) in Xalapa, Veracruz, classifying them according to their place of origin (rural, suburban and urban areas) and their age, occupation, prior clinical state, Histological variety and treatment given. Material and methods. A longitudinal, retrospective and descriptive study was performed in patients diagnosed with CUC, who were seen in the Cancer Center (CECan) from the first of January of 2006 to the 31 of December of 2008. Results. 314 cases of CUC were registered (more than 104 a year) classified in 117 rural patients (37%), 63 suburban patients (20%) and 134 urban patients (43%). The general average age was 48.2 years old. The urban age was 47.5. The suburban age was 47.8; and the rural, an average age of 49.4. Of those 314 cases, more than 51% didn’t have their Papanicolaou test 1 done, being as follows, 66 (56.4) in the rural areas, 33 (52.3%) in the suburban areas and 63 (47%) in the urban areas. In the women who did have the Papanicolau, the Histopathological concordance was 44%. There were False Negatives in 67 (36.4%) of the cases, reported as Inflammatory Altercations. In the last 3 years, only 116 (37%) of women had the 3 groups; and in general, the clinical Studies I and II occupied 71% of the 314 cases of CUC. Conclusions. The Cervical Cytology Smears should have a sufficient Diagnostic Quality for a correct interpretation; Lower overall rates of the False Negatives in the Reading Centers of Ginecological Cytology Nationwide; High coverage in rural and marginal areas; General information to the general public about the Papanicolaou and the Risk Factors of the Disease; Increase the participation of the urban and suburban areas in sureenings; Concentrate on women at risk in rural and suburban areas; have a minimum coverage of 80%.

REFERENCES

1. Alonso de Ruiz P, Lazcano PE, Hernández AM. Cáncer cervicouterino. 1ª ed. México (DF): Editorial Médica Panamericana; 2000.

2. Meneses GA, Mohar Betancourt A. Principales neoplasias malignas en México. 1ª ed. México (DF): Manual Moderno; 1999.

3. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society; 2005.

4. Dunn JE, Schweitzer V. The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974. Am J Obstet Gynecol 1981; 139: 868-76.

5. Bernard BV, Coughlin SS et al. Cervical cancer incidence in the United States by area of residence, 1998-2001.Obstet and Gynecol 2007; 110: 681-686.

6. Centers for disease control and prevention. DATA 2010. The healthy people 2010 database. [serial on line] [cited july 2007]; 1 (8): [24 screens]. Available from: http://wonder.cdc.gov/data2010/

7. Edelman MA, Menz BL. Selected comparisons and implications of a national rural and urban survey on health care acces, demographics and policy issues. J Rural Health 1996; 12: 197-205.

8. Hartley D, Quan L, Lurie N. Urban and rural differences in health insurance and acces to care. J Rural Health 1994; 10: 98-108.

9. Stearns SC, Slifkin RT, Edin HM. Acces to care for rural Medicare Beneficiaries. J Rural Health 2000; 16: 31-42.

10. Coronel-Brizio P, Guzmán GR. Cáncer ginecológico y de la glándula mamaria en el Centro Estatal de Cancerología de Veracruz. S.S. Clin Invest Gin Obst 2002; 29(6): 219-23.

11. Yabroff KR, Lawrwnce WFy cols. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening and use of recommended treatment? J Rural Health 2005; 21: 149-57.